122 related articles for article (PubMed ID: 29194036)
21. Prognostic value of epidermal growth factor receptor in node-positive breast cancer.
Grimaux M; Romain S; Remvikos Y; Martin PM; Magdelénat H
Breast Cancer Res Treat; 1989 Oct; 14(1):77-90. PubMed ID: 2690971
[TBL] [Abstract][Full Text] [Related]
22. The role of EGFR-directed therapy in the treatment of breast cancer.
Morris C
Breast Cancer Res Treat; 2002 Oct; 75 Suppl 1():S51-5; discussion S57-9. PubMed ID: 12353824
[TBL] [Abstract][Full Text] [Related]
23. EGFR mutation status in plasma and tumor tissues in non-small cell lung cancer serves as a predictor of response to EGFR-TKI treatment.
Que D; Xiao H; Zhao B; Zhang X; Wang Q; Xiao H; Wang G
Cancer Biol Ther; 2016; 17(3):320-7. PubMed ID: 26785777
[TBL] [Abstract][Full Text] [Related]
24. Value of epidermal growth factor receptor, HER2, p53, and steroid receptors in predicting the efficacy of tamoxifen in high-risk postmenopausal breast cancer patients.
Knoop AS; Bentzen SM; Nielsen MM; Rasmussen BB; Rose C
J Clin Oncol; 2001 Jul; 19(14):3376-84. PubMed ID: 11454885
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of epidermal growth factor receptor (EGFR) in breast cancer patients. Results of a follow-up study on 149 patients.
Railo MJ; Smitten KV; Pekonen F
Acta Oncol; 1994; 33(1):13-7. PubMed ID: 8142117
[TBL] [Abstract][Full Text] [Related]
26. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
[TBL] [Abstract][Full Text] [Related]
27. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
28. The predictive value of epidermal growth factor receptor expression for sensitivity to vinorelbine in breast cancer.
Ning YL; Qi CJ; Lu XZ; Zhu YL; Qian KQ; Zhao JZ
Basic Clin Pharmacol Toxicol; 2011 Dec; 109(6):499-505. PubMed ID: 21740526
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer.
Banys-Paluchowski M; Witzel I; Riethdorf S; Rack B; Janni W; Fasching PA; Solomayer EF; Aktas B; Kasimir-Bauer S; Pantel K; Fehm T; Müller V
Sci Rep; 2017 Dec; 7(1):17307. PubMed ID: 29229933
[TBL] [Abstract][Full Text] [Related]
30. EGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia.
Kallel I; Khabir A; Boujelbene N; Abdennadher R; Daoud J; Frikha M; Aifa S; Sallemi-Boudawara T; Rebaï A
J Recept Signal Transduct Res; 2012 Jun; 32(3):142-9. PubMed ID: 22394363
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-up.
Ferrero JM; Ramaioli A; Largillier R; Formento JL; Francoual M; Ettore F; Namer M; Milano G
Ann Oncol; 2001 Jun; 12(6):841-6. PubMed ID: 11484962
[TBL] [Abstract][Full Text] [Related]
32. Predictive molecular markers of response to epidermal growth factor receptor(EGFR) family-targeted therapies.
Barton S; Starling N; Swanton C
Curr Cancer Drug Targets; 2010 Dec; 10(8):799-812. PubMed ID: 20718710
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis.
Ding S; Wu J; Lin C; Andriani L; Goh C; Chen W; Li Y; Shen K; Zhu L
Oncologist; 2019 Nov; 24(11):e1014-e1023. PubMed ID: 31019021
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
35. What is the biological, prognostic, and therapeutic role of the EGF receptor in human breast cancer?
Harris AL
Breast Cancer Res Treat; 1994 Jan; 29(1):1-2. PubMed ID: 8018960
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer.
Tsutsui S; Kataoka A; Ohno S; Murakami S; Kinoshita J; Hachitanda Y
Clin Cancer Res; 2002 Nov; 8(11):3454-60. PubMed ID: 12429634
[TBL] [Abstract][Full Text] [Related]
37. The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs.
Zhang Y; Feng YC; Zhu HG; Xiong TC; Hou YS; Song J; Jiang W; Zhu CJ
Medicine (Baltimore); 2018 Jul; 97(30):e11648. PubMed ID: 30045314
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.
Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer.
Müller V; Witzel I; Pantel K; Krenkel S; Lück HJ; Neumann R; Keller T; Dittmer J; Jänicke F; Thomssen C
Anticancer Res; 2006; 26(2B):1479-87. PubMed ID: 16619561
[TBL] [Abstract][Full Text] [Related]
40. Clinical value of epidermal growth factor receptor expression in primary breast cancer.
Rampaul RS; Pinder SE; Nicholson RI; Gullick WJ; Robertson JF; Ellis IO
Adv Anat Pathol; 2005 Sep; 12(5):271-3. PubMed ID: 16210923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
